Annual Drug Patent Expirations for SAMSCA
Samsca is a drug marketed by Otsuka America Pharm and is included in one NDA. It is available from two suppliers. There are two patents protecting this drug and two Paragraph IV challenges.
Drug patent litigation for SAMSCA.
This drug has sixty-four patent family members in nineteen countries.
The generic ingredient in SAMSCA is tolvaptan. Two suppliers are listed for this compound. Additional details are available on the tolvaptan profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com